This book is the first systematic, detailed treatment of the approaches to ethical issues taken by biotech and pharmaceutical companies. The application of genetic/genomic technologies raises a whole spectrum of ethical questions affecting global health that must be addressed. Topics covered in this comprehensive survey include considerations for bioprospecting in transgenics, genomics, drug discovery, and nutrigenomics, as well as how to improve stakeholder relations, design ethical clinical trials, avoid conflicts of interest, and establish ethics advisory boards. The expert authors represent multiple disciplines including law, medicine, bioinformatics, pharmaceutics, business, and ethics.

An introduction to the increasingly important role of ethics in bioscience companies
Reviews
"Biotechnology and pharmaceutical companies are often driven by profit goals, but the case studies in Bioindustry Ethics show that this is increasingly not at the expense of ethical integrity. ...lend[s] important insights to other executives and professionals who might be developing their own practices and policies." - GENOMICS & PROTEOMICS (August 2005)



Book Information
ISBN 9780123693709
Author David L. Finegold
Format Paperback
Page Count 384
Imprint Academic Press Inc
Publisher Elsevier Science Publishing Co Inc
Weight(grams) 610g